BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, May 1, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

July 6, 2018

View Archived Issues

CB-4211 potentiates insulin effects on fatty acid metabolism and glucose homeostasis

Read More

CYP11B1 enzyme, a potential predictive biomarker for healing failure in diabetic foot ulcers

Read More

Serum netrin-1, a potential early biomarker for impaired fasting glucose and type 2 diabetes

Read More

NOVA2 or DDX6 mutations alter RNA metabolism leading to intellectual disability

Read More

[89]Zr-DFO-dinutuximab as novel radiotracer for selective detection of GD2-positive tumors

Read More

MR-438 peptidomimetic presented as a new radiosensitizing agent in medulloblastoma

Read More

Topline results announced from phase I study of ZYN-001 THC-prodrug patch

Read More

Expanded indication for Sprycel approved in Europe to include treatment of children with CP-CML

Read More

Safety review committee recommends continuation of phase Ib/II SENSITIZE study

Read More

Phase IIb study of LL-37 receives approval in Sweden

Read More

Vertex Pharmaceuticals presents new azoles for demyelinating diseases

Read More

Detection of NDMA in Zhejiang Huahai's valsartan leads to EMA review and product recall

Read More

Boehringer Ingelheim divulges SLC13A5 inhibitors

Read More

EMA validates Clovis' application for Rubraca as maintenance treatment for recurrent ovarian cancer

Read More

Icahn School of Medicine at Mount Sinai discloses PROTAc compounds for cancer

Read More

Nanjing TransThera Biosciences synthesizes protein kinase inhibitors for cancer

Read More

Zydus Cadila and CSIR-IMTECH collaborate to tackle drug-resistant infections

Read More

Medshine Discovery and collaborator patent CCR-2 and CCR-5 antagonists

Read More

Herantis initiates development program for noninvasive CDNF

Read More

Topline results from final analysis of phase II trial of BAN-2401 in Alzheimer's

Read More

MHRA approves Xonvea in U.K. for nausea and vomiting of pregnancy

Read More

Regulus Therapeutics announces corporate restructuring

Read More

Enzyvant partners with Visikol on digital pathology assay to support RVT-802

Read More

Takeda advances acquisition of TiGenix

Read More

Introducing BioWorld Science: supporting R&D decisions through drug discovery and preclinical news

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 30, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Chinabio 2026 partnering

    Chinese biotechs gain leverage as partners in dealmaking

    BioWorld
    China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • Roche identifies new TREM2 agonists

    BioWorld Science
    F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing